Form 4 Filing for NovoCure Ltd

This filing details a transaction by Vernon W. Anthony, a director at NovoCure Ltd, on April 28, 2026. Anthony acquired 21,500 ordinary shares at a price of $11.39 per share. Following this transaction, Anthony holds 200,602 ordinary shares. Additionally, an option to buy 21,500 ordinary shares, with an exercise price of $11.39, was exercised and disposed of on the same date. This transaction resulted in 0 shares from this option. The filing was signed by Steven Robbins as attorney in fact for Vernon W. Anthony.